版本:
中国

BRIEF-Stemline Therapeutics Q4 loss per share $0.56

March 16 Stemline Therapeutics Inc

* Stemline therapeutics reports fourth quarter 2016 financial results

* Q4 loss per share $0.56

* Q4 earnings per share view $-0.55 -- Thomson Reuters I/B/E/S

* Qtrly grant revenue $299,401 versus $205,651 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐